Neurotransmitters in the TME: Can Dopamine and Glutamate Be the Next Cancer Targets?. Journal of Biomolecules, Pathogenesis and Therapeutics, [S. l.], v. 2, n. 3, p. 111–112, 2026. DOI: 10.68041/jbpt.v2i3/01. Disponível em: https://jbptjournal.org/index.php/jbpt/article/view/81. Acesso em: 24 sep. 2026.